Cargando…

PSA-selective activation of cytotoxic human serine proteases within the tumor microenvironment as a therapeutic strategy to target prostate cancer

Prostate cancer is the most diagnosed malignancy and the second leading cause of cancer-related death in American men. While localized therapy is highly curative, treatments for metastatic prostate cancer are largely palliative. Thus, new innovative therapies are needed to target metastatic tumors....

Descripción completa

Detalles Bibliográficos
Autores principales:	Rogers, Oliver C., Anthony, Lizamma, Rosen, D. Marc, Brennen, W. Nathaniel, Denmeade, Samuel R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976476/ https://www.ncbi.nlm.nih.gov/pubmed/29854290 http://dx.doi.org/10.18632/oncotarget.25091

Ejemplares similares

Albumin-linked prostate-specific antigen-activated thapsigargin- and niclosamide-based molecular grenades targeting the microenvironment in metastatic castration-resistant prostate cancer
por: Akinboye, Emmanuel S., et al.
Publicado: (2019)

Quantification of Mesenchymal Stem Cells (MSCs) at Sites of Human Prostate Cancer
por: Brennen, W. Nathaniel, et al.
Publicado: (2012)

Mesenchymal stem cell infiltration during neoplastic transformation of the human prostate
por: Brennen, W. Nathaniel, et al.
Publicado: (2017)

The effect of the frequency and duration of prostate specific antigen (PSA) measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer
por: Paller, CJ, et al.
Publicado: (2013)

Mipsagargin: The Beginning—Not the End—of Thapsigargin Prodrug-Based Cancer Therapeutics
por: Isaacs, John T., et al.
Publicado: (2021)

Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection
por: Höti, Naseruddin, et al.
Publicado: (2023)

Editorial: Serine protease inhibitors and their therapeutic applications
por: Crocetti, Letizia, et al.
Publicado: (2022)

Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC
por: Sena, Laura A., et al.
Publicado: (2022)

Serine protease inhibitors decrease metastasis in prostate, breast, and ovarian cancers
por: Sananes, Amiram, et al.
Publicado: (2023)

Extracellular: Plasma Membrane Proteases – Serine Proteases
por: Antalis, T.M., et al.
Publicado: (2016)

The role of Serine Proteases and Serine Protease Inhibitors in the migration of Gonadotropin-Releasing Hormone neurons
por: Drapkin, Paola T, et al.
Publicado: (2002)

Targeted delivery of cytotoxic proteins to prostate cancer via conjugation to small molecule urea-based PSMA inhibitors
por: Rogers, O. C., et al.
Publicado: (2021)

Concise Review: Mesenchymal Stem Cell‐Based Drug Delivery: The Good, the Bad, the Ugly, and the Promise
por: Krueger, Timothy E. G., et al.
Publicado: (2018)

Identification and Characterization of Fusolisin, the Fusobacterium nucleatum Autotransporter Serine Protease
por: Doron, Lior, et al.
Publicado: (2014)

Serine Proteases of Parasitic Helminths
por: Yang, Yong, et al.
Publicado: (2015)

Cytokeratin 8 Is an Epithelial Cell Receptor for Pet, a Cytotoxic Serine Protease Autotransporter of Enterobacteriaceae
por: Nava-Acosta, Raul, et al.
Publicado: (2013)

Murine osteoclasts secrete serine protease HtrA1 capable of degrading osteoprotegerin in the bone microenvironment
por: Ochiai, Nagahiro, et al.
Publicado: (2019)

Does normalizing PSA after successful treatment of chronic prostatitis with high PSA value exclude prostatic biopsy?
por: Azab, Sherif, et al.
Publicado: (2012)

Origin and Expansion of the Serine Protease Repertoire in the Myelomonocyte Lineage
por: Weiss, Stefanie A. I., et al.
Publicado: (2021)

Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
por: Strittmatter, F, et al.
Publicado: (2011)

Antibodies to Serine Proteases in the Antiphospholipid Syndrome
por: Chen, Pojen P., et al.
Publicado: (2010)

The Relationship between Prostate Biopsy Results and PSA and Free PSA Ratio Changes in Elevated Serum PSA Patients with and without Antibiotherapy
por: Duran, Mesut Berkan, et al.
Publicado: (2020)

A Comparative Performance Analysis of Total PSA, Percentage Free PSA, PSA Velocity, and PSA Density versus the Detection of Primary Circulating Prostate Cells in Predicting Initial Prostate Biopsy Findings in Chilean Men
por: Murray, Nigel P., et al.
Publicado: (2014)

Association of Polymorphisms in the Prostate-Specific Antigen (PSA) Gene Promoter with Serum PSA Level and PSA Changes after Dutasteride Treatment in Korean Men with Benign Prostatic Hypertrophy
por: Park, Sung Woon, et al.
Publicado: (2010)

Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
por: Chang, Tsung-Hsin, et al.
Publicado: (2020)

Antigenic determinants of prostate-specific antigen (PSA) and development of assays specific for different forms of PSA.
por: Nilsson, O., et al.
Publicado: (1997)

Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer
por: Tomioka, Atsushi, et al.
Publicado: (2014)

Time to PSA rise differentiates the PSA bounce after HDR and LDR brachytherapy of prostate cancer
por: Burchardt, Wojciech, et al.
Publicado: (2018)

Clinical Use of [-2]proPSA (p2PSA) and Its Derivatives (%p2PSA and Prostate Health Index) for the Detection of Prostate Cancer: A Review of the Literature
por: Abrate, Alberto, et al.
Publicado: (2014)

Genome-wide survey of prokaryotic serine proteases: Analysis of distribution and domain architectures of five serine protease families in prokaryotes
por: Tripathi, Lokesh P, et al.
Publicado: (2008)

Establishment of reference intervals for serum [−2]proPSA (p2PSA), %p2PSA and prostate health index in healthy men
por: Wu, Zhi-Yu, et al.
Publicado: (2019)

Targeted inhibition of cell-surface serine protease Hepsin blocks prostate cancer bone metastasis
por: Tang, Xi, et al.
Publicado: (2014)

Association of serum prostate-specific antigen (PSA) level and circulating tumor cell-based PSA mRNA in prostate cancer
por: Cho, Hyungseok, et al.
Publicado: (2022)

Membrane-Anchored Serine Proteases in Health and Disease
por: Antalis, Toni M., et al.
Publicado: (2011)

Electrostatic recognition in substrate binding to serine proteases
por: Waldner, Birgit J., et al.
Publicado: (2018)

Structural and functional diversities in lepidopteran serine proteases
por: Srinivasan, Ajay, et al.
Publicado: (2006)

Fungal lifestyle reflected in serine protease repertoire
por: Muszewska, Anna, et al.
Publicado: (2017)

Effects of Bacillus Serine Proteases on the Bacterial Biofilms
por: Mitrofanova, Olga, et al.
Publicado: (2017)

Serine Proteases in the Lectin Pathway of the Complement System
por: Andrade, Fabiana A., et al.
Publicado: (2017)

Regulation of Neutrophil Serine Proteases by Intracellular Serpins
por: Benarafa, Charaf
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0t72jgf50b3sqocpa8i5m96k8o